School of Population Health and Clinical Practice, The University of Adelaide, North Terrace, Adelaide 5005, SA, Australia.
Soc Sci Med. 2012 Dec;75(12):2191-9. doi: 10.1016/j.socscimed.2012.08.016. Epub 2012 Aug 27.
Internationally, there is an increasing focus on quality and sustainability measures oriented to reducing inefficiencies in health provision. The use of assisted reproductive technologies (ART) for older women represents a case study in this area. This paper analyses the constructions of evidence brought to bear by ART physicians in the context of deliberative stakeholder engagements (held 2010) around options for restricting public subsidy of ART in Australia. Physicians participated in two deliberative engagements during which they were presented with results of a systematic review of ART effectiveness, as well as ethical and cost analyses. These sessions were part of a broader research program of engagements held with policymakers, community members and consumers. Physicians deliberated around the data presented with a view to formulating an informed contribution to policy. The ensuing discussions were transcribed and subject to discourse analysis. Physicians questioned the evidence presented on the grounds of 'currency', 'proximity', 'selectivity' and 'bias'. We outline physicians' accounts of what should count as evidence informing ART policy, and how this evidence should be counted. These accounts reflect implicit decisions around both the inclusion of evidence (selection) and the status it is accorded (evaluation). Our analysis suggests that participatory policy processes do not represent the simple task of assessing the quality/effectiveness of a given technology against self-evident criteria. Rather, these processes involve the negotiation of different orders of evidence (empirical, contextual and anecdotal), indicating a need for higher-level discussion around 'what counts and how to count it' when making disinvestment decisions.
在国际上,越来越关注质量和可持续性措施,以减少卫生服务提供中的低效现象。使用辅助生殖技术(ART)为老年妇女提供服务就是这方面的一个案例研究。本文分析了在澳大利亚限制公共资助辅助生殖技术的选择方面进行的审议利益攸关方参与(2010 年举行)中,ART 医生提出的证据构建。医生们参加了两次审议会议,会上他们了解了辅助生殖技术效果的系统评价结果,以及伦理和成本分析。这些会议是与政策制定者、社区成员和消费者进行更广泛的参与性研究计划的一部分。医生们围绕所提供的数据进行了审议,以期为政策制定做出明智的贡献。随后的讨论被转录并进行了话语分析。医生们以“时效性”、“接近度”、“选择性”和“偏见”为由对所提出的证据提出质疑。我们概述了医生们对告知辅助生殖技术政策的证据应该是什么以及应该如何衡量的看法。这些观点反映了在纳入证据(选择)和赋予其地位(评估)方面的隐含决策。我们的分析表明,参与式政策过程不仅仅是根据自我明证的标准评估给定技术的质量/有效性的简单任务。相反,这些过程涉及到不同类型证据(经验、背景和轶事)的协商,表明在做出撤资决策时,需要围绕“什么重要以及如何衡量”进行更高级别的讨论。